MyAverix Finance
US · Healthcare
Genelux Corporation Common Stock (GNLX)
Biotechnology
Genelux Corporation Common Stock (GNLX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GNLX
Genelux Corporation Common Stock (GNLX) — FAQ
What is GNLX's P/E ratio?
The price-to-earnings (P/E) ratio for Genelux Corporation Common Stock (GNLX) is 25.00 (data as of 2026-05-23).
Does Genelux Corporation Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Genelux Corporation Common Stock (GNLX). Check the MyAverix Finance app for the latest dividend data.
What sector is Genelux Corporation Common Stock in?
Genelux Corporation Common Stock (GNLX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GNLX listed on?
GNLX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.